9.1 Agenda
Ordinary business
- Adoption of the individual company financial statements for Fiscal 2025.
- Adoption of the consolidated financial statements for Fiscal 2025.
- Appropriation of net income for Fiscal 2025; determination of the dividend amount and payment date.
- Appointment of Bellon SA as a director for a three-year (3-year) term.
- Appointment of Geneviève Bich as a director for a three-year (3-year) term.
- Appointment of Françoise Colpron as a director for a three-year (3-year) term.
- Reappointment of Luc Messier as a director for a three-year (3-year) term.
- Approval of the components of compensation paid during or awarded for Fiscal 2025 to Sophie Bellon, Chairwoman and CEO.
- Approval of the information related to the compensation of Corporate Officers and directors paid during or awarded for Fiscal 2025, as referred to in article L.22-10-9 I of the French Commercial Code.
- Approval of the compensation policy applicable to the directors.
- Approval of the compensation policy applicable to the Chairwoman and CEO for the period from September 1, 2025 to November 9, 2025 (included).
- Approval of the compensation policy applicable to the Chairwoman of the Board of Directors as from November 10, 2025.
- Approval of the compensation policy applicable to the Chief Executive Officer as from November 10, 2025.
- Authorization for the Board of Directors to purchase shares of the Company.
Extraordinary business
- Delegation of powers to the Board of Directors to increase the Company's share capital - with preferential subscription rights for existing shareholders - by issuing ordinary shares and/or other securities carrying immediate or deferred rights to the Company's capital.
- Delegation of powers to the Board of Directors to increase the Company's share capital by capitalizing premiums, reserves, profits, or other sums eligible for capitalization.
- Authorization for the Board of Directors to grant existing and/or newly issued restricted shares to all or certain employees and/or corporate officers of the Group, with automatic waiver by shareholders of their preferential subscription rights.
- Delegation of powers to the Board of Directors to increase the Company's share capital - without preferential rights for existing shareholders - by issuing ordinary shares and/or other securities carrying immediate or deferred rights to the Company's capital, reserved for members of employee share purchase plans.
- Authorization for the Board of Directors to reduce the Company’s share capital by canceling treasury shares.
Ordinary business
- Powers to carry out formalities.